Feedback / Questions
Tecentriq (atezolizumab) - Roche
Tecentriq: Regulatory submissions in US/EU in combination with paclitaxel for 1L TNBC in 2020
(Roche)
-
Jan 30, 2020 -
Regulatory submissions in US/EU in combination with nab-paclitaxel for adjuvant TNBC in 2020
European regulatory • sBLA
http://roche.com/dam/jcr:6c0035b5-3447-4b2c-aeae-9649f5197ccb/en/irp200130.pdf
Jan 30, 2020
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious